RetSight
Advanced Ophthalmic Diagnostic Imaging Technology
Company Overview
Snapshot
Founded in January 2016 by Eduardo Svetliza, RetSight operates with 1–10 employees. The company ceased operations in January 2022, having focused on developing innovative ophthalmic diagnostic imaging systems.
Business overview
RetSight specializes in developing innovative, low-cost ophthalmic diagnostic imaging systems. Its core technology provides large retinal coverage through a quick procedure designed to replace existing ophthalmic diagnostic devices. The company's products aimed to serve both preterm infant and adult markets, with plans to sell or lease systems to hospitals, eye clinics, and ophthalmologists. RetSight operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices.
Log in to access full profile ›Company Intelligence Q&A
- What is RetSight's primary focus?
- RetSight focuses on developing innovative, low-cost ophthalmic diagnostic imaging systems that offer large retinal coverage through quick procedures, aiming to replace existing diagnostic devices.
- When was RetSight founded?
- RetSight was founded in January 2016.
- Who is a co-founder of RetSight?
- Eduardo Svetliza is a co-founder and CTO of RetSight.
- What markets does RetSight target?
- RetSight's products are designed to cover both the preterm infant and adult markets, with plans to serve hospitals, eye clinics, and ophthalmologists.
- What is the current operational status of RetSight?
- RetSight ceased operations in January 2022.